Literature DB >> 9685412

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase.

B G Darnay1, V Haridas, J Ni, P A Moore, B B Aggarwal.   

Abstract

Various members of the tumor necrosis factor (TNF) receptor superfamily interact directly with signaling molecules of the TNF receptor-associated factor (TRAF) family to activate nuclear factor kappaB (NF-kappaB) and the c-Jun N-terminal kinase (JNK) pathway. The receptor activator of NF-kappaB (RANK), a recently described TNF receptor family member, and its ligand, RANKL, promote survival of dendritic cells and differentiation of osteoclasts. RANK contains 383 amino acids in its intracellular domain (residues 234-616), which contain three putative TRAF-binding domains (termed I, II, and III). In this study, we set out to identify the region of RANK needed for interaction with TRAF molecules and for stimulation of NF-kappaB and JNK activity. We constructed epitope-tagged RANK (F-RANK616) and three C-terminal truncations, F-RANK330, F-RANK427, and F-RANK530, lacking 85, 188, and 285 amino acids, respectively. From this deletion analysis, we determined that TRAF2, TRAF5, and TRAF6 interact with RANK at its C-terminal 85-amino acid tail; the binding affinity appeared to be in the order of TRAF2 > TRAF5 > TRAF6. Furthermore, overexpression of RANK stimulated JNK and NF-kappaB activation. When the C-terminal tail, which is necessary for TRAF binding, was deleted, the truncated RANK receptor was still capable of stimulating JNK activity but not NF-kappaB, suggesting that interaction with TRAFs is necessary for NF-kappaB activation but not necessary for activation of the JNK pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685412     DOI: 10.1074/jbc.273.32.20551

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  107 in total

Review 1.  Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.

Authors:  B G Darnay; B B Aggarwal
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  RANK is essential for osteoclast and lymph node development.

Authors:  W C Dougall; M Glaccum; K Charrier; K Rohrbach; K Brasel; T De Smedt; E Daro; J Smith; M E Tometsko; C R Maliszewski; A Armstrong; V Shen; S Bain; D Cosman; D Anderson; P J Morrissey; J J Peschon; J Schuh
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

Review 3.  Regulation of osteoclast formation and function.

Authors:  L T Duong; G A Rodan
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

4.  IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappaB.

Authors:  Y Abu-Amer
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

5.  TNFRSF11A and TNFSF11 are associated with age at menarche and natural menopause in white women.

Authors:  Yan Lu; Pengyuan Liu; Robert R Recker; Hong-Wen Deng; Volodymyr Dvornyk
Journal:  Menopause       Date:  2010 Sep-Oct       Impact factor: 2.953

Review 6.  Role of NF-κB in the skeleton.

Authors:  Deborah Veis Novack
Journal:  Cell Res       Date:  2010-11-16       Impact factor: 25.617

Review 7.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

8.  TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation.

Authors:  Betty Lamothe; William K Webster; Ambily Gopinathan; Arnaud Besse; Alejandro D Campos; Bryant G Darnay
Journal:  Biochem Biophys Res Commun       Date:  2007-06-11       Impact factor: 3.575

9.  Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.

Authors:  Kuzhuvelil B Harikumar; Ajaikumar B Kunnumakkara; Kwang S Ahn; Preetha Anand; Sunil Krishnan; Sushovan Guha; Bharat B Aggarwal
Journal:  Blood       Date:  2008-10-24       Impact factor: 22.113

10.  Disruption of the transcription factor RBP-J results in osteopenia attributable to attenuated osteoclast differentiation.

Authors:  Jing Ma; Ya-Li Liu; Yi-Yang Hu; Ya-Ning Wei; Xing-Cheng Zhao; Guang-Ying Dong; Hong-Yan Qin; Yin Ding; Hua Han
Journal:  Mol Biol Rep       Date:  2012-12-07       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.